Understanding how insulin interacts with its receptor to improve diabetes treatment
Rare-event simulation and analysis for elucidating mechanisms of development and disease
This study is looking at how insulin works with its receptor on a tiny level to help create better and easier-to-use insulin treatments for people with diabetes, especially in places where resources are limited.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10831479 on NIH RePORTER |
What this research studies
This research focuses on using advanced computational methods to simulate and analyze the interactions between insulin and its receptor at a molecular level. By bridging the gap between short simulation times and longer biological processes, the study aims to uncover the mechanisms of insulin binding and self-assembly. This could lead to improved insulin therapies that are more effective and easier to use, especially in areas with limited resources. Patients may benefit from insights that could enhance the design of insulin analogs and their delivery methods.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes who may benefit from improved insulin treatments.
Not a fit: Patients who do not have diabetes or those who are not using insulin therapies may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and accessible insulin therapies for diabetes patients.
How similar studies have performed: Previous research has shown promise in using computational methods to analyze protein interactions, suggesting that this approach could yield valuable insights.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Dinner, Aaron — University of Chicago
- Study coordinator: Dinner, Aaron
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.